Blue Jet Healthcare Limited (NSE:BLUEJET)
India · Delayed Price · Currency is INR 446.40
-6.10 (-1.35%)
Jun 3, 2026, 12:41 PM IST
Blue Jet Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 9,473 | 10,300 | 7,116 | 7,210 | 6,835 | |
Revenue Growth (YoY) | -8.03% | 44.74% | -1.30% | 5.49% | 36.99% |
Cost of Revenue | 4,358 | 4,695 | 3,212 | 3,427 | 2,946 |
Gross Profit | 5,115 | 5,605 | 3,904 | 3,783 | 3,889 |
Selling, General & Admin | 735.35 | 609.97 | 531.85 | 418.97 | 330.3 |
Other Operating Expenses | 1,439 | 1,218 | 1,080 | 1,173 | 1,066 |
Operating Expenses | 2,414 | 2,006 | 1,893 | 1,843 | 1,614 |
Operating Income | 2,701 | 3,599 | 2,011 | 1,940 | 2,275 |
Interest Expense | -62.39 | -0.98 | -1.61 | -13.59 | -32.82 |
Interest & Investment Income | - | 53.99 | 28.18 | 5.87 | 4.38 |
Currency Exchange Gain (Loss) | - | 183.03 | 99.27 | 147.66 | 167.53 |
Other Non Operating Income (Expenses) | 686.54 | 39.38 | 14.34 | 13.89 | 2.38 |
EBT Excluding Unusual Items | 3,325 | 3,875 | 2,152 | 2,094 | 2,417 |
Gain (Loss) on Sale of Investments | - | 183.65 | 142.09 | 71.11 | 19.36 |
Gain (Loss) on Sale of Assets | - | 2.51 | 4.72 | 1.03 | 0.29 |
Asset Writedown | - | - | - | - | -3.85 |
Other Unusual Items | - | - | -97.43 | - | - |
Pretax Income | 3,325 | 4,061 | 2,201 | 2,166 | 2,432 |
Income Tax Expense | 846.96 | 1,009 | 563.44 | 565.84 | 616.39 |
Earnings From Continuing Operations | 2,478 | 3,052 | 1,638 | 1,600 | 1,816 |
Net Income | 2,478 | 3,052 | 1,638 | 1,600 | 1,816 |
Net Income to Common | 2,478 | 3,052 | 1,638 | 1,600 | 1,816 |
Net Income Growth | -18.80% | 86.38% | 2.33% | -11.88% | 31.19% |
Shares Outstanding (Basic) | 173 | 173 | 173 | 173 | 173 |
Shares Outstanding (Diluted) | 173 | 173 | 173 | 173 | 173 |
Shares Change (YoY) | -0.03% | - | - | - | - |
EPS (Basic) | 14.29 | 17.59 | 9.44 | 9.23 | 10.47 |
EPS (Diluted) | 14.29 | 17.59 | 9.44 | 9.23 | 10.47 |
EPS Growth | -18.76% | 86.33% | 2.33% | -11.88% | 31.19% |
Free Cash Flow | 1,147 | -341.16 | 683.96 | 822.85 | 1,246 |
Free Cash Flow Per Share | 6.61 | -1.97 | 3.94 | 4.74 | 7.18 |
Dividend Per Share | 1.200 | 1.200 | 1.000 | - | - |
Dividend Growth | - | 20.00% | - | - | - |
Gross Margin | 54.00% | 54.42% | 54.86% | 52.47% | 56.89% |
Operating Margin | 28.51% | 34.95% | 28.27% | 26.91% | 33.29% |
Profit Margin | 26.16% | 29.63% | 23.01% | 22.20% | 26.57% |
Free Cash Flow Margin | 12.11% | -3.31% | 9.61% | 11.41% | 18.23% |
EBITDA | 2,941 | 3,760 | 2,275 | 2,148 | 2,484 |
EBITDA Margin | 31.05% | 36.50% | 31.98% | 29.80% | 36.35% |
D&A For EBITDA | 240.02 | 160.41 | 264 | 208.11 | 209.35 |
EBIT | 2,701 | 3,599 | 2,011 | 1,940 | 2,275 |
EBIT Margin | 28.51% | 34.95% | 28.27% | 26.91% | 33.29% |
Effective Tax Rate | 25.47% | 24.84% | 25.60% | 26.12% | 25.34% |
Revenue as Reported | 10,160 | 10,762 | 7,405 | 7,449 | 7,029 |